We analyzed a large cohort of newly diagnosed and intensively treated AML patients according to their mutational status of BCOR and BCORL1. The respective proportions of mBCOR and mBCORL1 in the cohort were comparable to those reported in recent studies [6,21,26,27]. The gene discussed is BCORL1; the disease is acute myeloid leukemia.